[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.54.109. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Capitol Health Call
September 17, 2008

FDA Enforcement Lags

JAMA. 2008;300(11):1290. doi:10.1001/jama.300.11.1290-d

A Government Accountability Office (GAO) report issued July 28 found the Food and Drug Administration (FDA) to be slow in reacting to pharmaceutical manufacturers' impermissible promotions of off-label drug use.

The report (http://www.gao.gov/new.items/d08835.pdf) looked at the years 2003 through 2007 and found that the FDA issued 42 regulatory letters asking drug companies to stop off-label promotion. The FDA took an average of 7 months to issue these letters from the time they were first drafted. In addition, companies cited for more serious violations took an average of 4 months to take the corrective actions requested.

First Page Preview View Large
First page PDF preview
First page PDF preview
×